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The soluble protein arrestin (also named 48K-protein or retinal-S-antigen) is involved in controlling light-dependent 
transducin and cGMP phosphodiesterase activity in retinal rods. It is also known for its ability to induce autoimmune 
reactions in the eye causing the eye disease uveitis. We report here a rapid binding of ATP to arrestin with KA = 2 x lCF1 
(l/moly and a coordination number n = 3. This ATP binding to arrestin supports the notion of a nucleotide exchange 
which initiates the rapid inhibitory action of this enzyme during the primary step of vertebrate phototransduction. 
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1. INTRODUCTION 
In the vertebrate photoreceptor the signal 
transduction mechanism is initiated by the light in- 
duced formation of a metastable state of the 
photopigment rhodopsin (37 kDa). From this in- 
termediate state, the meta II rhodopsin, the light 
activation is rapidly transferred to channel pro- 
teins in the envelope membrane which control the 
ion currents of the receptor. This phototransduc- 
tion process is mediated by the combined action of 
4 receptor proteins: a nucleotide binding protein, 
transducin (79 kDa), acts as a diffusible transmit- 
ter giving alternatively contact between the light- 
activated meta II rhodopsin and inhibited 
phosphodiesterase (PDE) molecules [l]. In this 
step the PDE is activated to hydrolyze cyclic 
guanosine monophosphate (cGMP) which is sup- 
posed to keep ion channels open in the receptor 
plasma membrane [2]. The transducin process has 
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a high chemical amplification yielding 100-500 ac- 
tivated PDE per bleached rhodopsin [2]. The reac- 
tion cascade is finally stopped by the action of a 
third receptor protein, arrestin (45 kDa), which 
binds to the meta II rhodopsin. Kuhn et al. showed 
that an effective arrestin binding that suppresses a
further PDE activation could not be obtained 
before bleached rhodopsin is phosphorylated by 
the activity of a fourth receptor protein, rhodopsin 
kinase (68 kDa). The phosphorylation takes place 
at the protein chain which contains the C-terminal 
end [3-51. At first sight, this would suggest a bind- 
ing of arrestin to these phosphate groups at the 
end chain, known as regulatory unit [6]. This view 
might further be supported by the recent finding of 
Yamaki et al. that in the amino acid sequence of 
arrestin one has three specific binding pockets for 
phosphate groups [7]. But there is other evidence 
that arrestin does not necessarily bind this way: 
suppose the phosphate groups of the activated 
rhodopsin make contact indeed with the binding 
pockets of arrestin. Then one would expect that a 
maximum of 3 of them would be sufficient for a 
successful binding. The transducin activation of 
bleached rhodopsin, however, is not blocked by ar- 
restin before more than 6 sites at the regulatory 
unit are being phosphorylated [8,9]. As a matter of 
fact, arrestin is found to bind also to the meta II 
rhodopsin state prior to its phosphorylation. This 
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binding is totally blocked by ATP [lo]. These 
results suggest a different type of binding to occur 
at the phosphate binding sites of arrestin. 
Moreover, the sequence analysis studies done by 
Shinohara et al. show certain similarities between 
arrestin and the T,-subunit of transducin especial- 
ly with regard to a possible binding of nucleotides 
[11,12]. 
Actually, this communication gives direct 
evidence that 3 ATP molecules can bind strongly 
to arrestin and that this binding is influenced by 
ADP. This finding gives new insight in the possible 
role of arrestin as an ADP/ATP-exchange protein 
and thus a counterpart of transducin in the light 
regulation of the phototransduction process. This 
view of arrestin interaction in the phototransduc- 
tion process is generally applicable whether trans- 
ducin is regarded as activator of phosphodiesterase 
activity - as commonly agreed to above - or as a 
direct blocker of cGMP-opened ion channels - as 
recently suggested on the basis of new electro- 
physiological findings [ 131. 
2. MATERIALS AND METHODS 
2.1. Preparation of arrestin 
To obtain highly active arrestin for binding studies, in princi- 
ple the method described by Kuhn [14] and Pfister [15] was used 
with a special modification concerning the preparation of rod 
outer segments (ros) to enhance the protein yield: bovine eyes 
were gathered at the slaughterhouse and kept warm near body 
temperature until the retinae could be removed 2-3 h after 
enucleation of the eye bulbs. 
The retinae were isolated from the open eye cub and stored 
in Ringer’s solution [16]. Different from the normal procedure, 
however, under continuous stirring the retinal tissues were il- 
luminated in Ringer’s solution for 20 min by the light of a 
150 W incandescent lamp filtered by an orange glass filter 
(Schott, Mainz, FRG, OG 590; 1 mm). After illumination the 
ros preparation followed the normal procedure [16]. The fur- 
ther preparation of arrestin from light adapted retinal rods was 
done by the known method cited above [14,15]. 
A quantitative protein assay was achieved by a method 
described by Bradford [17]. The protein was determined using 
SDS-PAGE chromatography [18]. Employing the light adapta- 
tion step the yield in arrestin could be enhanced to 7-8% of the 
original rhodopsin contents as compared to l-3% without light 
adaptation [lo]. The arrestin obtained by this procedure show- 
ed on the average a 75% activity with respect o ATP-binding 
(see below). 
2.2. Preparation of ‘100 mM’ protein extract 
A second protein extract was obtained from bovine outer seg- 
ment suspensions which besides arrestin contained rhodopsin 
kinase, too. For this purpose, a ros-suspension was homogeniz- 
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ed by ultrasonification (B12, Branson, Danbury, CT, USA) in 
a KCl-Tris-buffer (100 mM KCI, 10 mM Tris-HCl, 3 mM 
MgCl2, 1 mM DTT, pH 7.4) and then centrifuged for 15 min 
at 45000 x g (RCSB, rotor SS-34, Sorvall Inc., Newton, CT, 
USA). The supernatant solution is the ‘100 mM’ extract which 
contains the two proteins [lo]. 
2.3. Measurement of ATP binding 
The binding of ATP to arrestin was measured in a 
luminometer (1250, LKB, Bromma, Sweden) using the standard 
buffer and the ATP-monitoring reagent of LKB employing the 
luciferin/luciferase system as described by Chapelle [19] and 
Thore [20]. 
In preliminary, qualitative experiments a certain amount of 
ATP was given to the test buffer solution first and the cor- 
responding luminescence level measured. Thereafter a small 
volume (5-10 ,ul) of the protein-solution - 100 mM extract or 
arrestin - was added and the decreasing level of luminescence 
measured. For performing quantitative binding studies the 
calibration of luminescence l vels and the measurement of ATP 
consumption could readily be done in the luminometer during 
the same set of experiments. In each case, a series of equal 
volume aliquots of ATP solution (I = 1.. .N, N = 5.. . 10, Av = 
5-10 pl, CATP: 1 x 10m6 M) was given to the luminometer solu- 
tion (250~1) one in addition to the previously added arrestin- 
extract (approx. 50 pmol), the other one, for calibration, to the 
pure buffer solution. From these two sets of luminescence l vels 
(cf. fig.3) the amount of free and bound ATP was determined 
by the height and the difference of corresponding levels at equal 
number 1. 
3. RESULTS 
From the chromatographic SDS-PAGE plots 
shown in fig. 1 it is evident that the arrestin extract 
from a bovine rod outer segment preparation con- 
tains this protein (45 kDa) nearly in its pure form. 
The other 100 mM protein extract, however, in- 
cludes both arrestin (45 kDa) and rhodopsin 
kinase (68 kDa) as well. The rapid ATP binding to 
arrestin is illustrated in fig.2. In fig.2A the 
luminescence level is shown which is measured 
after the addition of ATP by which a concentra- 
tion of 1 nM is obtained. This luminescence level 
is decreased within the luminometer time resolu- 
tion (co.2 s) as soon as the arrestin-extract is add- 
ed. In fig.2B the ATP-consumption is measured 
which is caused by the addition of the 100 mM- 
protein extract. At first a rapid ATP binding is 
observed - shown by the negative jump in 
luminescence level - followed by a further linear 
decrease of luminescence. Obviously, this protein 
extract effects both the rapid ATP binding by ar- 
restin and the enzymatic action of the rhodopsin 
kinase in consuming ATP as well. 
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Fig.1. SDS-PAGE gels from 100 mM-extract (A) and pure 
arrestin-extract (8). 
These first qualitative results gave strong 
evidence that a binding of ATP to arrestin exists at 
the conditions of these experiments. To study the 
binding properties the same luminescence method 
was used. Fig.3 shows a series of lu~nescence 
levels measured when equal amounts of ATP are 
successively given to the luminometer buffer solu- 
tion. These levels are always lower if arrestin has 
previously been added (fig.3A) than the correspon- 
ding calibration levels (fig.3B) where arrestin has 
been omitted. The concentration values of free and 
bound ATP are readily calculated from the cor- 
responding levels. 
A plot of bound ATP vs the free ATP on a 
linear concentration scale (see fig.4) yields the 
saturation value c&m of maximum binding of ATP 
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Fig.3. The luminescence of a sample with (A) and without (B) 
arrestin is measured. Equal volumes (Av = 8 pl, 1 = 1.. 3) of 
ATP-solution, cont.: 1 x 1(X6 M are added. From the 
difference in corresponding intensity levels (equal number f) 
between A (free ATP, CA) and B (total ATP) the amount of 
bound ATP (AC*) is determined. 
(A) to arrestin. In case of a stoichiometric binding 
of ATP (A) to arrestin (s) according to: 
S -I- nA 5 S.A, (1) 
(K = association equilibrium constant, n = max- 
imal number of ATP-molecules bound to arrestin) 
the relation for the bound (AC_+) vs free ATP con- 
centration (CA) should be: 
CA,m l+Kc”A 
(2) 
A numerical fit to this equation (see solid line in 
fig.4A) as well as separate Hill-plot (fig.4B) accor- 
ding to: 
Fig.2 Rapid ATP binding of arrestin ~Luminometer 1250, 
LKB). (A) 1, standard; 2, ATP level (IO-’ mot); 3, 10~1 
arrestin, cont.: 6 x lo-’ M. (B) 1, standard; 2, ATP level 
(lo-lo mol); 3, 5 pl 108 mM-extract, cont.: 1.5 x 10m6 M. 
In ’ - = In K/4 + nln(cA/c,) 
1-d 
(3) 
(where co = standard concentration, e.g. nM), 
yields n = 3 -I 0.3 and K = (2 rt 0.3) x 102’ 
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Fig.4. Plot of bound ATP (AC*) versus free ATP (CA). One 
measurement of five. (Upper part) Linear plot, sigmoidal 
binding curve; (lower part) logarithmic Hill plot, slope shows 
coordination number n = 3 (2.98). 
(l/mol)3. These data could be obtained as mean 
value from at least 5 separate measurements at dif- 
ferent preparations and slightly varied procedures. 
According to eqn 2 the effective protein concen- 
tration & for ATP binding can be given by the 
maximum binding capacity ca,,/n = c’;‘. On the 
other hand, at the experiment shown in fig.4A the 
protein concentration measured by the Bradford 
method is cr, = 530 nM. A comparison with the ex- 
perimental Value for m~imum binding c&m = 
(50 + 5) nM (asymptote in fig.4A) results in an ef- 
ficiency y = cZ/c, = 0.95 ~fr 0.2 in the activity of 
arrestin for ATP binding. In the average overall 
experiments in this binding study the arrestin 
preparation has an efficiency y = 0.75 + 0.2 for 
stoichiometric binding of ATP. 
In additional still preliminary experiments ADP 
was given also to the test solution: contrary to ex- 
pectation ADP did not inhibit the binding of ATP 
to arrestin but seemed rather to promote it. The 
conclusion is that ADP does not bind directly to 
arrestin at least not at the same binding sites. 
4. DISCUSSION 
The binding studies presented in this short com- 
munication prove that ATP binds to arrestin with 
a coordination number of 3 and a relatively high 
association constant. This finding was supported 
by the sequence analysis of arrestin published by 
Yamaki et al. [7] just after the first results of the 
ATP-binding study were obtained: the amino acid 
sequence of arrestin shows 3 binding sites for 
phosphate groups but no specific nucleotide bind- 
ing areas. On average, each of these phosphate 
‘pockets’ have positive charges in its close vicinity 
(see fig.5). This finding suggests, that during the 
ATP binding to arrestin the outer phosphate 
groups of the negatively charged ATP interact with 
the positively charged phosphate binding sites. The 
absolute value of the association constant indicates 
that the ATP binding to arrestin occurs already at 
low ATP concentrations. Half-saturation for bind- 
ing is found at 80 nM of free ATP. 
The predominant question to be discussed is 
whether this particular ATP binding has 
significance for the signal transmission in the 
vertebrate photoreceptor. The answer is suggested 
by some further results obtained from arrestin 
binding studies especially with respect to 
nucleotide interactions. First of all, there is the 
observation by flash photometric studies both 
from light absorption and scattering changes that 
arrestin binds already to photoexcited rhodopsin 
(meta II state) prior to the phosphorylation by the 
rhodopsin kinase and that this binding is inhibited 
by ATP and not by ADP [lo]. On the other hand, 
there is growing evidence that a permanent arrestin 
binding to phosphorylated meta II rhodopsin 
alone does not allow for its final disactivation if 
the amount of arrestin in the receptor cell is 
8-10% of rhodopsin (211. Therefore, if the 
rhodopsin bleach exceeds 10% of rhodopsin excess 
meta II rhodopsin should be found which cannot 
bind to arrestin. Thus photoactivation should par- 
tially persist which is not the case [Q]. Further- 
more, kinetic studies of light scattering with 
ARG ARG GLY ILE ALA LEU ASP GLY LYS ILE LYS 
(B) W (N) (t-4 (N) W) (A) (N) (B) W) (a) 
Fig.5. Part of amino acid sequence of phospboryl-binding sites 
from bovine arrestin (AA 290-300) and amino acid charge (N 
= neutral; A = acidophihc; B = basic) from Yamaki et al. [7]. 
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stacked discs indicate that arrestin undergoes a 
nucleotide exchange during the binding process 
like transducin does [22]. 
The results of this study directly support the idea 
of an arrestin model that employs a nucleotide ex- 
change. In the ADP form arrestin should have a 
high affinity to photoexcited rhodopsin but not in 
the ATP form. The affinity of ADP-arrestin to 
phosphorylated meta II rhodopsin should be 
higher than that of GDP-transducin. Therefore, it 
is concluded that the photoexcited rhodopsin R*-P 
is inhibited by a dynamic rather than by a static 
process very likely by means of a transient ATPase 
activity during the binding period [22]. The ATP 
binding shown here should reflect the ATP uptake 
of arrestin in its ADP form which takes place at 
moderate ATP concentrations already (80 mM). 
The ADP binding, its correlation to the ATP up- 
take as well as the assumed ATPase activity is sub- 
ject of current studies of the arrestin-binding 
process. 
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